Cargando…
Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling
BACKGROUND: Meningioma growth rates are highly variable, even within benign subgroups, with some remaining stable, whereas others grow rapidly. OBJECTIVE: To identify molecular-genetic markers for more accurate prediction of meningioma recurrence and better-targeted therapy. METHODS: Microarrays ide...
Autores principales: | Slavik, Hanus, Balik, Vladimir, Vrbkova, Jana, Rehulkova, Alona, Vaverka, Miroslav, Hrabalek, Lumir, Ehrmann, Jiri, Vidlarova, Monika, Gurska, Sona, Hajduch, Marian, Srovnal, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566524/ https://www.ncbi.nlm.nih.gov/pubmed/32125436 http://dx.doi.org/10.1093/neuros/nyaa009 |
Ejemplares similares
-
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence
por: Slavik, Hanus, et al.
Publicado: (2022) -
Recent Advances in Methods for Circulating Tumor Cell Detection
por: Vidlarova, Monika, et al.
Publicado: (2023) -
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
por: Vidlarova, Monika, et al.
Publicado: (2022) -
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
por: Rehulkova, Alona, et al.
Publicado: (2023) -
The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study
por: Kalita, Ondrej, et al.
Publicado: (2021)